Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

HRB May 6, 2026

H&R Block Q3 FY2026 Earnings Call - Assisted Channel Market Share Stabilizes as AI-Driven Expertise Gains Traction

H&R Block delivered a strong third quarter of fiscal 2026, beating expectations on revenue, EBITDA, and adjusted EPS while raising its full-year outlook. The company stabilized its assisted channel ma...

  • H&R Block beat Q3 fiscal 2026 expectations, reporting revenue of $2.4 billion (up 5.3% YoY), EBITDA of $1.1 billion (up 5.9%), and adjusted EPS of $6.02 (up 11.9%).
  • The company raised its full-year fiscal 2026 guidance, now expecting revenue of $3.91-$3.92 billion, EBITDA of $1.025-$1.035 billion, and adjusted EPS of $5.10-$5.20.
  • Assisted channel market share stabilized this tax season, holding flat against industry growth after two consecutive years of progressive improvement, marking a key inflection point.
  • +9 more takeaways
EVTC May 6, 2026

Evertec Q1 2026 Earnings Call - Dimensa Acquisition Closes, Full-Year Outlook Raised Amid Latin America Growth

Evertec reported strong Q1 2026 results, driven by a full quarter contribution from Tecnobank and organic growth across segments, with revenue up 8% year-over-year to $247.9 million. The company close...

  • Evertec closed the Dimensa acquisition, expanding its footprint in Latin America’s insurance and risk management verticals and positioning itself as a larger financial SaaS provider.
  • Q1 2026 revenue reached $247.9 million, up 8% year-over-year, with constant currency growth of approximately 5%.
  • Full-year 2026 revenue guidance raised to $1.073-$1.085 billion, reflecting 15.1%-16.4% reported growth and 13.8%-15% constant currency growth.
  • +7 more takeaways
BLBD May 6, 2026

Blue Bird Corporation Q2 FY2026 Earnings Call - Record Profits and Strategic Acquisition Lift Outlook

Blue Bird delivered a record second quarter for fiscal 2026, beating guidance on every metric with $51 million in Adjusted EBITDA and $40 million in free cash flow. The company sold 2,148 buses, with ...

  • Record Q2 Adjusted EBITDA of $51 million and free cash flow of $40 million, beating guidance for the 14th consecutive quarter.
  • Full-year revenue guidance raised to $1.725 billion-$1.775 billion, with Adjusted EBITDA projected at $235 million-$255 million post-Micro Bird acquisition.
  • Completed acquisition of the remaining 50% stake in Micro Bird JV, expanding total addressable market by 78% and adding Buy America commercial shuttle bus capabilities.
  • +7 more takeaways
HCI May 6, 2026

HCI Group First Quarter 2026 Earnings Call - Record Earnings Drive Aggressive Share Buybacks

HCI Group delivered a record first quarter with pre-tax income up 15% to $115 million and diluted EPS of $5.45. The company reported an 8% growth in gross premiums earned and a 12% increase in total r...

  • Pre-tax income grew 15% year-over-year to $115 million, with diluted EPS of $5.45, marking the strongest first quarter in company history.
  • Gross premiums earned increased just over 8%, while total revenue surged more than 12% due to significant growth in investment and other income.
  • The combined ratio held steady at 57%, matching full-year 2025 performance, and management is targeting a 60% ±5% combined ratio going forward.
  • +7 more takeaways
CENT May 6, 2026

Central Garden & Pet Fiscal 2026 Q2 Earnings Call - Record Quarter Driven by Operational Discipline and Strategic Simplification

Central Garden & Pet delivered a record second quarter and first half in fiscal 2026, driven by strong execution, operational simplification, and resilient demand across both Pet and Garden segments. ...

  • Central Garden & Pet reported record Q2 and H1 fiscal 2026 results with net sales of $906 million, up 9% year-over-year, driven by strong underlying demand and favorable timing shifts.
  • Operating margin expanded to 12.6% in Q2 from 11.2% in the prior year, with gross margin improving 30 basis points to 33.1%, reflecting productivity gains and mix benefits.
  • Diluted EPS reached a record $1.28, beating expectations and supporting maintained full-year guidance of $2.70 or better, excluding acquisitions and restructuring.
  • +7 more takeaways
ZVIA May 6, 2026

Zevia Q1 2026 Earnings Call - Record Sales Growth Driven by Cardi B Partnership and Cost Discipline

Zevia delivered a record first quarter in 2026, with net sales jumping 21.2% to $46.1 million and adjusted EBITDA flipping to a positive $0.9 million from a $3.3 million loss a year earlier. The surge...

  • Net sales grew 21.2% year-over-year to $46.1 million, marking the highest growth rate since the company went public.
  • Adjusted EBITDA turned positive at approximately $0.9 million, a significant improvement from a $3.3 million loss in the prior year period.
  • Management raised full-year net sales guidance to $170 million–$175 million, reflecting a 7% growth midpoint, but lowered full-year adjusted EBITDA expectations to a loss of $2 million–$4 million.
  • +7 more takeaways
QTRX May 6, 2026

Quanterix Q1 2026 Earnings Call - New CEO Executes Sharp Commercial Pivot and Accelerates Alzheimer's Diagnostics Push

Quanterix delivered a mixed Q1 2026 report that underscores a company in active transition. Revenue rose 20% year-over-year to $36.4 million, but organic growth declined 21% as academic and pharma end...

  • Revenue rose 20% YoY to $36.4 million, but organic revenue declined 21%, reflecting sluggish academic and pharma end-markets.
  • New CEO Everett Cunningham is executing a sharp strategic pivot, shifting focus from synergy integration to aggressive growth and commercial execution.
  • The company successfully delivered the $85 million in annualized cost synergies from the Akoya acquisition, allowing the combined entity to operate at pre-acquisition expense levels.
  • +10 more takeaways
LIFE May 6, 2026

Ethos Technologies Q1 2026 Earnings Call - Revenue Doubles as Platform Economics Scale and Guidance Rises

Ethos Technologies delivered a record first quarter, more than doubling revenue year-over-year to $193 million while protecting over 88,000 new policies. The company’s vertically integrated platform c...

  • Revenue surged 104% year-over-year to $193 million, driven by 136% growth in the direct channel and 42% growth in the third-party channel.
  • Adjusted EBITDA reached $34 million, supported by a Rule of 40 score of 121, reflecting strong growth and profitability despite a one-time charge.
  • Management raised full-year 2026 revenue guidance to $561–$565 million and adjusted EBITDA guidance to $103–$107 million.
  • +7 more takeaways
IBEX May 6, 2026

IBEX Q3 FY 2026 Earnings Call - Record Revenue Growth Driven by Health Tech Expansion and Sierra AI Partnership

IBEX delivered another quarter of outsized execution, posting record revenue of $164.4 million, up 17% year-over-year, and adjusted EPS of $0.91, up 11%. The growth was not a broad sweep. It was highl...

  • Record revenue of $164.4 million, up 17% year-over-year, driven by broad-based growth across verticals and geographic regions.
  • Health tech vertical emerged as the primary growth engine, surging 54% and on track to exceed $100 million in annual revenue by year-end.
  • Technology vertical grew 43%, while telecommunications declined 23.1%, indicating a deliberate shift away from lower-margin legacy clients.
  • +7 more takeaways
GRDN May 6, 2026

Guardian Pharmacy Services Q1 2026 Earnings Call - IRA Transition Holds Firm as EBITDA Guidance Rises

Guardian Pharmacy Services navigated its first full quarter under the Inflation Reduction Act framework with disciplined execution, delivering 2% reported revenue growth and 27% adjusted EBITDA growth...

  • Guardian reported $336.6 million in Q1 2026 revenue, up 2% year-over-year, with management noting that low-double-digit growth would have occurred absent IRA-mandated pricing declines on branded drugs.
  • Adjusted EBITDA surged 27% to $29.8 million, driven by a $3 million one-time discrete benefit from favorable payer dynamics and a manufacturer inventory credit, which management explicitly stated is non-recurring.
  • Full-year adjusted EBITDA guidance was raised to $123-$127 million from $120-$124 million, while revenue guidance remains unchanged at $1.4-$1.42 billion, reflecting confidence in underlying volume growth despite headwinds.
  • +7 more takeaways